EUR 133.7
(-0.04%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 6.75 Billion USD | -16.5% |
2022 | 8.09 Billion USD | 19.98% |
2021 | 6.74 Billion USD | -8.41% |
2020 | 7.36 Billion USD | 11.36% |
2019 | 6.61 Billion USD | 2.46% |
2018 | 6.45 Billion USD | 30.26% |
2017 | 4.95 Billion USD | 10.85% |
2016 | 4.46 Billion USD | -8.22% |
2015 | 4.86 Billion USD | 33.37% |
2014 | 3.65 Billion USD | -0.19% |
2013 | 3.65 Billion USD | 528.35% |
2012 | 582 Million USD | 1.22% |
2011 | 575 Million USD | -19.13% |
2010 | 711 Million USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | 6.77 Billion USD | 0.22% |
2024 Q2 | 6.74 Billion USD | -0.38% |
2023 Q4 | 6.75 Billion USD | 0.15% |
2023 Q1 | 6.74 Billion USD | -16.66% |
2023 FY | 6.75 Billion USD | -16.5% |
2023 Q3 | 6.74 Billion USD | 0.0% |
2023 Q2 | 6.74 Billion USD | 0.04% |
2022 Q4 | 8.09 Billion USD | 19.87% |
2022 Q3 | 6.74 Billion USD | 0.22% |
2022 Q1 | 6.73 Billion USD | -0.1% |
2022 FY | 8.09 Billion USD | 19.98% |
2022 Q2 | 6.73 Billion USD | -0.03% |
2021 Q1 | 7.35 Billion USD | -0.16% |
2021 Q2 | 7.34 Billion USD | -0.1% |
2021 Q3 | 6.75 Billion USD | -8.05% |
2021 Q4 | 6.74 Billion USD | -0.13% |
2021 FY | 6.74 Billion USD | -8.41% |
2020 Q2 | 7.85 Billion USD | 18.54% |
2020 Q3 | 7.86 Billion USD | 0.17% |
2020 Q4 | 7.36 Billion USD | -6.37% |
2020 FY | 7.36 Billion USD | 11.36% |
2020 Q1 | 6.62 Billion USD | 0.17% |
2019 Q3 | 6.61 Billion USD | 0.02% |
2019 FY | 6.61 Billion USD | 2.46% |
2019 Q4 | 6.61 Billion USD | -0.08% |
2019 Q1 | 6.57 Billion USD | 1.95% |
2019 Q2 | 6.61 Billion USD | 0.56% |
2018 Q3 | 6.44 Billion USD | 29.99% |
2018 FY | 6.45 Billion USD | 30.26% |
2018 Q4 | 6.45 Billion USD | 0.17% |
2018 Q2 | 4.95 Billion USD | 0.02% |
2018 Q1 | 4.95 Billion USD | 0.02% |
2017 Q1 | 4.46 Billion USD | 0.0% |
2017 Q2 | 4.56 Billion USD | 2.26% |
2017 Q3 | 5.7 Billion USD | 24.8% |
2017 Q4 | 4.95 Billion USD | -13.14% |
2017 FY | 4.95 Billion USD | 10.85% |
2016 Q1 | 4.46 Billion USD | -8.22% |
2016 Q2 | 4.46 Billion USD | 0.02% |
2016 Q3 | 4.46 Billion USD | -0.04% |
2016 FY | 4.46 Billion USD | -8.22% |
2016 Q4 | 4.46 Billion USD | 0.02% |
2015 FY | 4.86 Billion USD | 33.37% |
2015 Q4 | 4.86 Billion USD | 33.96% |
2015 Q2 | 3.64 Billion USD | 0.05% |
2015 Q1 | 3.64 Billion USD | -0.14% |
2015 Q3 | 3.63 Billion USD | -0.36% |
2014 Q4 | 3.65 Billion USD | -0.05% |
2014 Q1 | 3.65 Billion USD | 0.03% |
2014 Q2 | 3.65 Billion USD | -0.11% |
2014 FY | 3.65 Billion USD | -0.19% |
2014 Q3 | 3.65 Billion USD | -0.05% |
2013 Q1 | 3.64 Billion USD | 526.46% |
2013 FY | 3.65 Billion USD | 528.35% |
2013 Q4 | 3.65 Billion USD | 0.14% |
2013 Q3 | 3.65 Billion USD | 0.0% |
2013 Q2 | 3.65 Billion USD | 0.16% |
2012 Q4 | 582 Million USD | 0.34% |
2012 Q3 | 580 Million USD | 1.22% |
2012 FY | 582 Million USD | 1.22% |
2012 Q1 | 579 Million USD | 0.7% |
2012 Q2 | 573 Million USD | -1.04% |
2011 Q4 | 575 Million USD | 0.0% |
2011 FY | 575 Million USD | -19.13% |
2010 FY | 711 Million USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
MPH Health Care AG | 13.05 Million EUR | -51644.807% |
Apontis Pharma AG | 6 Million EUR | -112483.333% |
Dermapharm Holding SE | 1.08 Billion EUR | -525.238% |
Evotec SE | 626.19 Million EUR | -978.732% |
MERCK Kommanditgesellschaft auf Aktien | 9.94 Billion EUR | 32.049% |
PharmaSGP Holding SE | 73.97 Million EUR | -9031.216% |
SynBiotic SE | 3.68 Million EUR | -183447.114% |